A-A-0053375(DM)
1 March 1988
INTERIM COMMERCIAL ITEM DESCRIPTION
CYTARABINE, STERILE, USP
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Materiel, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient characteristics:
Shall be Cytarabine, Sterile, USP.
All ingredients shall be of pharmaceutical grade.
Shall be in accordance with the requirements of the USP.
For Strength 1, shall contain 100 mg of Cytarabine per vial, wihtin the applicable assay limits for injections.
For Strength 2, shall contain 500 mg of Cytarabine per vial, wihtin the applicable assay limits for injections.
Workmanship. The injection shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Package (PG).
For Strength 1, shall be supplied 100 mg in a vial. One package containing one vial, together with one 5 ml ampul of Bacteriostatic Water for Injection, as specified, constitutes one unit.
For Strength 2, shall be supplied 500 mg in a vial. One package containing one vial, together with one 5 ml ampul of Bacteriostatic Water for Injection, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business